Merck & Co., Inc. (BCBA:MRK)

Argentina flag Argentina · Delayed Price · Currency is ARS
32,280
-280 (-0.86%)
At close: Dec 30, 2025
37.36%
Market Cap384.15T
Revenue (ttm)88.03T
Net Income (ttm)26.09T
Shares Outn/a
EPS (ttm)10,355.40
PE Ratio14.73
Forward PE11.58
Dividend632.42 (1.94%)
Ex-Dividend DateDec 15, 2025
Volume1,228
Average Volume4,095
Open32,540
Previous Close32,560
Day's Range32,220 - 32,840
52-Week Range16,950 - 33,200
Beta0.30
RSI63.88
Earnings DateFeb 3, 2026

About Merck & Co.

Merck & Co., Inc. operates as a healthcare company worldwide. The company offers human health pharmaceutical for various areas under the Keytruda, Welireg, Gardasil, ProQuad, M−M−R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. It also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, B... [Read more]

Sector Healthcare
Founded 1891
Employees 75,000
Stock Exchange Buenos Aires Stock Exchange
Ticker Symbol MRK
Full Company Profile

Financial Performance

In 2024, Merck & Co.'s revenue was $64.17 billion, an increase of 6.74% compared to the previous year's $60.12 billion. Earnings were $17.12 billion, an increase of 4589.59%.

Financial numbers in USD Financial Statements

News

There is no news available yet.